Hexagon Capital Partners LLC - RIGEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Hexagon Capital Partners LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$24
-14.3%
220.0%0.00%
Q2 2023$28
-3.4%
220.0%0.00%
Q1 2023$29
-12.1%
220.0%0.00%
Q4 2022$33220.0%0.00%
Q3 2022$0220.0%0.00%
Q2 2022$0220.0%0.00%
Q1 2022$0220.0%0.00%
Q4 2021$0220.0%0.00%
Q3 2021$0220.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders